Sign In
Buy RPTX
$2.65
+0 (+0%)
At Close: Apr 24, 2026
Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans
04:09pm, Thursday, 31'st Dec 2020
CAMBRIDGE, Mass. & MONTREAL, Quebec--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its pr
Repare Therapeutics: CRISPR-Enabled Technology Might Unlock New Therapies
03:20pm, Monday, 28'th Dec 2020
Synthetic Lethality (SL) is a promising approach for cancer treatments. Repare's SNIPRx platform has the potential to identify SL pairs to create new therapies.
Repare Therapeutics Added to the NASDAQ Biotechnology Index
04:05pm, Thursday, 17'th Dec 2020
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics, Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprieta
Repare Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
07:00am, Monday, 23'rd Nov 2020
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietar
